Now let me write the final consolidated review.

## Summary

This paper identifies that molecular data distributions exhibit a "dense-concentrated structure" (DC-structure) — narrow, well-separated peaks in a low-density background — which makes standard diffusion models fragile because small errors at intermediate timesteps can overshoot thin peaks and land in unrecoverable low-density regions. The authors formalize this structure (Definition 3.1, Equations 6-7), analyze the overshoot mechanism, and propose DIST (Diffuse and Steer), a model-agnostic plug-in that filters the intermediate distribution by evaluating pilot trajectories and discarding batches that lead to invalid final molecules. Experiments on QM9 and GEOM-Drugs show consistent improvements across three backbone models (EDM, GeoLDM, RADM) with reduced inference cost.

## Strengths

- **A clear, formal diagnosis of why molecular diffusion is fragile.** The DC-structure formalization (Definition 3.1) and overshoot analysis (Equations 6-7) are the paper's most significant contribution. The argument that a reverse step in an overlap region can leap past a thin peak (β_t·Δ/σ_*² > cσ_*) is well-reasoned and goes beyond the vague observation that "molecules are hard to generate." Table 1 provides empirical support showing monotonic degradation with increasing t.

- **Consistent improvement across multiple backbones.** Table 2 shows that adding DIST improves EDM, GeoLDM, and RADM on all reported metrics for both QM9 and GEOM-Drugs. Gains on molecule stability are substantial (e.g., EDM: 82.0→89.9 on QM9). The use of published weights and specified datasets supports the claim of backbone-agnostic benefit.

- **Model-agnostic, no retraining required.** DIST does not modify the base diffusion model's weights or training procedure, making it a practical plug-in.

## Weaknesses

### Fatal
None.

### Major
None.

### Minor

- **Framing overstates the mechanism.** The method is described as "corrective sampling" that "steers" trajectories, but the actual mechanism (Section 3.2, "Corrective Sampling") is batch-level selection: generate candidate trajectories, run pilots to completion, and discard batches whose final outputs are unsatisfactory. This is distribution-level filtering, not real-time trajectory correction. The method is valid and clearly described, but the "steering" language implies a more active intervention than what occurs. The paper would be stronger if it honestly framed DIST as a rejection-sampling strategy motivated by the DC-structure diagnosis — which is a legitimate contribution even without a novel correction mechanism.

- **Efficiency accounting is unclear in the main text.** The explanation in Section 4.3 gives a formula (307 = (1000-300)/100 + 300) that does not account for pilot-run costs on rejected batches or the cost of rejected pilots. The paper references Appendix G.1 for a detailed quantification, but the main text alone risks misleading a reader about what is counted. Table 3 reports empirical averages of 413–637 timesteps vs. 1000 for baselines, which are plausible and suggest meaningful savings, but the derivation of these numbers and whether they include all computational overhead should be stated explicitly in the main text.

- **The scoring function s_j is not specified in the main text.** Section 3.2 lists four candidate scoring functions (round-trip residual, self-consistency, ensemble variance, or chemistry-based penalty) but does not say which was actually used. The paper defers to Appendix F for details, but the core decision of how trajectories are evaluated should be stated in the main text, since the entire selection procedure depends on it.

- **Proposition 3.1's bound assumes oracle-quality batch identification.** The theoretical bound (Appendix E.2) depends on knowing the true coverage α(τ) and having identified batches that align with p_t. In practice, DIST identifies "good" batches via a heuristic: running pilots to t=0 and evaluating their outputs. The gap between what the theory assumes and what the method implements is unbridged. Corollary 3.1 (TV-contraction) is a general property of any correction scheme and does not provide DIST-specific guarantees.

- **GEOM-Drugs results omit the most important metric.** The paper states that for GEOM-Drugs, stability metrics are omitted "following prior work, since they are consistently close to 0%." This means the metric where DIST shows the largest improvements (molecule stability) is unavailable for the larger dataset. The GEOM-Drugs results are limited to validity (96.0–99.8%), where absolute differences are small. Additionally, GEOM-Drugs results in Table 2 lack standard deviations (unlike QM9), making it hard to assess significance.

- **The "first to highlight" claim is overstated.** The paper claims to be "the first to highlight that molecular data distributions are highly concentrated and dense" (Contribution 1). Prior work on molecular generation has long recognized the constrained nature of chemical space. What is genuinely novel is the *formalization* (Definition 3.1) and the overshoot analysis — the paper would be better served by claiming "first to formalize" rather than "first to highlight."

### Trivial
None.

## Nice-to-Haves

- **Compute-controlled comparison.** The most informative experiment would compare DIST against baselines given the same total compute budget (FLOPs or wall time), not just the same number of accepted trajectories. This would strengthen the efficiency claim.

- **Scoring function ablation.** The paper ablates pilot sample size (Table 4) but not the choice of scoring function. A comparison across the four candidate functions would reveal whether the method is robust to this choice.

- **Standard deviations for GEOM-Drugs.** Reporting variance on the larger dataset would help assess whether the small absolute differences in validity are meaningful.

- **Sensitivity to intermediate timestep t.** The choice of t is a key hyperparameter. The paper notes an ablation in Appendix H, but the chosen values should be stated in the main text.

## Removed Points

These points appeared in the input review but were filtered per the specified rules:

- **"Scoring function never specified" as a critical issue.** The paper references Appendix F for detailed settings. Per the guidelines, appendix content is treated as existing. Demoted to Minor: a presentation choice rather than a missing specification.

- **"Efficiency claims likely undercount total cost" with specific worst-case calculation (150,000+ steps).** The critic's back-of-the-envelope calculation assumes 100 batches × 5 pilots × 300 steps, but the empirical averages in Table 3 (413–637) contradict this extreme scenario. The concern about unclear accounting is valid (kept as Minor), but the specific numeric claim is not supported by the paper's data.

- **"The theoretical guarantees do not connect to what the method implements" as a structural issue.** The gap between theory and practice is real but standard in ML papers — the theory provides conditional guarantees (if you identify the right batches, the error is bounded), and the practical question is whether the heuristic selection is good enough. This is not a structural flaw; demoted to Minor.

- **"Section-by-section notes on Abstract/Introduction claim."** The "first to highlight" point is kept as Minor; the rest of the section notes were editorial observations, not actionable weaknesses.

- **"Missing parts" (compute-controlled comparison, scoring function ablation, SDs for GEOM-Drugs).** These are constructive suggestions, not weaknesses. Moved to Nice-to-Haves.

## Novel Insights

The input review's most insightful observation is that the paper's strongest contribution is the DC-structure *diagnosis*, while the DIST method is better understood as a trajectory-selection / rejection-sampling strategy rather than a novel corrective mechanism. The reviewer correctly identifies that the formalization (Definition 3.1, Equations 6-7) stands on its own as a useful contribution, and that honest framing as "analysis + filtering heuristic" would strengthen rather than weaken the paper's credibility. The observation that Table 3's empirical timestep numbers (413-637) tell a different — more realistic — story than the simplified 307 calculation in Section 4.3 is also useful.

## Suggestions

1. Reframe the method honestly: acknowledge that DIST is a trajectory-selection (rejection sampling) strategy, not real-time steering. The DC-structure diagnosis motivates why selection is so important for molecular diffusion — this is a legitimate contribution.
2. State the scoring function used in the experiments explicitly in the main text (or at minimum, state which of the four candidates was used).
3. Clarify what computational costs are included in the efficiency numbers of Table 3 (include pilot runs, rejected batches, etc.). If the appendix already contains this, move a summary into the main text.
4. Add standard deviations to GEOM-Drugs results.
5. Tone down the "first to highlight" claim to "first to formalize."

## Score and Decision

<score>6</score>
<decision>Borderline Accept</decision>